Group 1 - The core point of the article is that the skincare brand Dermistry, under the parent company Rohto Pharmaceutical, plans to cease operations in China by December 11, 2025, as indicated by a notice on its Tmall flagship store [2][4] - Currently, the Dermistry store cannot be found on Taobao, and its last WeChat post was nearly two years ago, suggesting a significant decline in engagement and presence in the market [5] - Dermistry focuses on skin research and scientific ingredients, promoting a minimalist skincare philosophy, but has struggled to establish a differentiated advantage in the competitive Chinese beauty market [5] Group 2 - The article notes that several Japanese cosmetic brands have announced their exit from the Chinese market this year, facing pressure from declining performance and increasing competition [6] - Japanese brands are experiencing diminished advantages as imported brands, with domestic consumers becoming less inclined to choose imported products, contributing to the challenges faced by these companies [7]
乐敦制药旗下品牌肌本科被曝关闭天猫旗舰店
Xi Niu Cai Jing·2025-11-19 07:07